Status:

COMPLETED

Trial of Ropinirole in Motor Recovery After Stroke

Lead Sponsor:

University of California, Irvine

Collaborating Sponsors:

GlaxoSmithKline

Conditions:

Cerebrovascular Accident

Hemiparesis

Eligibility:

All Genders

18+ years

Phase:

PHASE2

Brief Summary

The purpose of this study is to assess efficacy, as well as safety, of Ropinirole in improving movement among patients with chronic stroke.

Detailed Description

Stroke is a leading cause of disability. Current treatments target injury and must be delivered within hours. A body of literature suggests that there are processes ongoing days-months after stroke th...

Eligibility Criteria

Inclusion

  • Stroke onset 4 weeks-12 months prior
  • Stroke is radiologically confirmed as either (a) ischemic or (b) hemorrhagic
  • Minimum age 18
  • No significant pre-stroke disability
  • No other stroke in previous 3 months
  • Absence of major depression
  • Fugl-Meyer (FM) motor score of 23-83 out of 100
  • Functional Independence Measure (FIM) ambulation-subscore of 3 or more, and 50 foot walk takes longer than 15 seconds

Exclusion

  • Significant daytime somnolence or any substantial decrease in alertness, language reception, or attention
  • Pregnant or lactating
  • Advanced liver, kidney, cardiac, or pulmonary disease
  • Orthostatic hypotension
  • Current use of ciprofloxacin, a centrally acting dopamine agonist, or a centrally active dopamine antagonist
  • A terminal medical diagnosis consistent with survival \< 1 year
  • Coexistent major neurological disease
  • Coexistent major psychiatric disease
  • A history of significant alcohol or drug abuse in the prior 3 years
  • A coexistent disease characterized by an abnormality of CNS dopaminergic tone
  • Current enrollment in another investigational study related to stroke or stroke recovery
  • Contraindication to ropinirole prescription

Key Trial Info

Start Date :

October 1 2003

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

May 1 2007

Estimated Enrollment :

52 Patients enrolled

Trial Details

Trial ID

NCT00221390

Start Date

October 1 2003

End Date

May 1 2007

Last Update

November 1 2016

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of California, Irvine Medical Center

Orange, California, United States, 92868